Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Flourishing in a Remote Workplace: Individual Techniques - 2This ‘CSI: Miami’ star spent years solving crimes on TV. Then she became the target of one herself.
- 3Why this Iranian island looks like Mars after it rains
- 4Which Store is Your Decision ?
- 5From Overpowered to Coordinated: Individual Accounts of Cleaning up
- Exploring the Main Year of Life as a parent: Individual Encounters
- Damaged Shenzhou-20 spacecraft to return to Earth uncrewed for inspection
- See the famous winged horse Pegasus fly in the autumn night sky
- The Best Web-based Courses for Ability Advancement
- The biggest black hole breakthroughs of 2025
- Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025
- Manual for 6 famous sorts of cheddar
- Germany's Bundestag extends two armed forces missions abroad
- True serenity: Investigating Emotional well-being and the Advantages of Contemplation
